Filing Flows › CV Sciences (CVSI) › Q1 2026
CV Sciences (CVSI) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
CV Sciences (CVSI) reported revenue of $3.2M for the first quarter 2026 (Q1 2026), -11% from a year earlier and -3% from the quarter before. Operating margin was -10.0%, net loss $643K (20.1% of revenue).
CV Sciences, Q1 2026: revenue $3.2M (-11% year over year), operating margin -10.0%, net loss $643K, operating cash flow $101K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | -3% | -11% |
| Operating profit | −$318K | — | -2991% |
| Net earnings | −$643K | — | — |
| Operating cash flow | $101K | — | — |
| Free cash flow | $98K | — | — |
What changed
Revenue was $3.2M in Q1 2026, down 11% year over year and down 3% from the previous quarter.
Gross margin was 48.9%, up 2.9 points from Q1 2025. Operating costs exceeded revenue by $318K, an operating margin of -10.0%. Operating expenses grew 14% against a revenue fall of 11%. The quarter ended with a net loss of $643K, wider than the previous quarter's $206K loss. Net interest and other expense of $325K was the main reason.
Operating cash flow was $101K. Non-cash charges added back $23K of depreciation and amortization and $148K of share-based compensation. Working capital and other items added $573K. Capital expenditures of $3K left free cash flow of $98K.
Questions
What was CV Sciences' revenue in the first quarter 2026?
CV Sciences (CVSI) reported revenue of $3.2M for the first quarter 2026 (Q1 2026), -11% from a year earlier and -3% from the quarter before.
Was CV Sciences profitable in the first quarter 2026?
Operating loss was $318K (-10.0% of revenue) and net loss $643K.
Source: CV Sciences 10-Q on SEC EDGAR.